Month: January 2021

Home / 2021 / January

Rare Disease Biotech Company, EryDel, names Esin Kosal, PhD as SVP, Regulatory Affairs

Category: BIOPHARMACEUTICALS | Comments Off on Rare Disease Biotech Company, EryDel, names Esin Kosal, PhD as SVP, Regulatory Affairs
Posted by Chartwell Partners | January 5, 2021

Chartwell Partners is pleased to announce the recruitment of Esin Kosal, PhD as SVP, Regulatory Affairs for EryDel SpA, a global biotechnology company utilizing its proprietary red blood cell drug delivery technology to encapsulate small and large molecules into a patient’s own red blood cells which are then reinfused into that patient in a fast,…